Epidemiology of Gastrointestinal Disease

  • Julia B. Greer
  • Haq Nawaz
  • Dhiraj Yadav


The elderly represent a unique cohort of the US population—and their numbers are on the rise. Among the medical community, being 65 years or older represents an age associated with multiple comorbid conditions and a point in life at which practitioners are typically less likely to advise aggressive diagnostic, medical, and surgical interventions for common medical conditions. It is increasingly recognized that a subset of older individuals live longer and healthier lives without major disease entities or limitations in functional status. Although aging is associated with declines in the cardiovascular, metabolic, renal, endocrine, musculoskeletal, immunologic, and neurologic systems, the gastrointestinal (GI) tract differs in its greater reserves and ability to maintain relatively normal digestive and absorptive function. Nonetheless, certain gastrointestinal disorders are more common and cause greater morbidity and mortality in the aged. Additionally, parallel diminished reserves in other systems may cause profound gastrointestinal effects and the contributing roles of depression, cognitive decline, lack of social support, and polypharmacy may further incite deleterious gastrointestinal consequences. Aging is also associated with the accumulation of genetic mutations and chromosomal instability, reflected in the higher incidence and mortality of GI cancers in the old.


Inflammatory Bowel Disease Acute Pancreatitis Chronic Pancreatitis Celiac Disease Peptic Ulcer Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    US Census. The 65 years and over population: 2000. Census 2000 Brief.Google Scholar
  2. 2.
    Everhart JE, editor. The burden of digestive diseases in the United States. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office; 2008. NIH Publication No. 09-6443.Google Scholar
  3. 3.
    Erwin WG. Common gastrointestinal diseases in the elderly. Geriatrics. 1988;43(Suppl):75–82.PubMedGoogle Scholar
  4. 4.
    Salles N. Basic mechanisms of the aging gastrointestinal tract. Dig Dis. 2007;25:112–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Harding SM, Richter JE. The role of gastroesophageal reflux in chronic cough and asthma. Chest. 1997;111:1389–402.PubMedCrossRefGoogle Scholar
  6. 6.
    Richter JE. Extraesophageal presentations of gastroesophageal reflux disease: the case for aggressive diagnosis and treatment. Cleve Clin J Med. 1997;64:37–45.PubMedGoogle Scholar
  7. 7.
    Richter JE, Hicks DM. Unresolved issues in gastroesophageal reflux-related ear, nose, and throat problems. Am J Gastroenterol. 1997;92:2143–4.PubMedGoogle Scholar
  8. 8.
    Heidelbaugh JJ, Gill AS, Van Harrison R, et al. Atypical presentations of gastroesophageal reflux disease. Am Fam Physician. 2008;78:483–8.PubMedGoogle Scholar
  9. 9.
    Collen MJ, Abdulian JD, Chen YK. Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy. Am J Gastroenterol. 1995;90:1053–7.PubMedGoogle Scholar
  10. 10.
    Brunt LM, Quasebarth MA, Dunnegan DL, et al. Is laparoscopic antireflux surgery for gastroesophageal reflux disease in the elderly safe and effective? Surg Endosc. 1999;13:838–42.PubMedCrossRefGoogle Scholar
  11. 11.
    Watanabe T, Chiba T, Watanabe T, et al. [Peptic ulcer in the elderly]. Nippon Rinsho Jpn J Clin Med. 2002;60 Suppl 2:603–7.Google Scholar
  12. 12.
    Khaghan N, Holt PR. Peptic disease in elderly patients. Can J Gastroenterol. 2000;14:922–8.PubMedGoogle Scholar
  13. 13.
    Ofman JJ, Etchason J, Alexander W, et al. The quality of care for Medicare patients with peptic ulcer disease. Am J Gastroenterol. 2000;95:106–13.PubMedCrossRefGoogle Scholar
  14. 14.
    Cullen DJ, Hawkey GM, Greenwood DC, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut. 1997;41:459–62.PubMedCrossRefGoogle Scholar
  15. 15.
    Farrell JJ, Friedman LS. Gastrointestinal bleeding in the elderly. Gastroenterol Clin North Am. 1981;30:377–407.CrossRefGoogle Scholar
  16. 16.
    Kaplan RC, Heckbert SR, Koepsell TD, et al. Risk factors for hospitalized gastrointestinal bleeding among older persons. Cardiovascular Health Study Investigators. J Am Geriatr Soc. 2001;49:126–33.PubMedCrossRefGoogle Scholar
  17. 17.
    Antler AS, Pitchumoni CS, Thomas E, et al. Gastrointestinal bleeding in the elderly. Morbidity, mortality and cause. Am J Surg. 1981;142:271–3.PubMedCrossRefGoogle Scholar
  18. 18.
    Kong MF, Horowitz M. Gastric emptying in diabetes mellitus: relationship to blood-glucose control. Clin Geriatr Med. 1999;15:321–38.PubMedGoogle Scholar
  19. 19.
    Chaudhuri TK, Fink S. Prognostic implication of gastroparesis in patients with diabetes mellitus. Clin Auton Res. 1992;2:221–4.PubMedCrossRefGoogle Scholar
  20. 20.
    O’Mahony D, O’Leary P, Quigley EM, et al. Aging and intestinal motility: a review of factors that affect intestinal motility in the aged. Drugs Aging. 2002;19:515–27.PubMedCrossRefGoogle Scholar
  21. 21.
    Carmel R. Nutritional anemias and the elderly. Semin Hematol. 2008;45(4):225–34.PubMedCrossRefGoogle Scholar
  22. 22.
    Joosten E, Meeuwissen J, Vandewinckele H, et al. Iron status and colorectal cancer in symptomatic elderly patients. Am J Med. 2008;121(12):1072–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Frey CF, Zhou H, Harvey DJ, et al. The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994–2001. Pancreas. 2006;33:336–44.PubMedCrossRefGoogle Scholar
  24. 24.
    Yadav D. Recent advances in the epidemiology of alcoholic pancreatitis. Curr Gastroenterol Rep. 2011;13(2):157–65.PubMedCrossRefGoogle Scholar
  25. 25.
    Rosenthal RA. Small-bowel disorders and abdominal wall hernia in the elderly patient. Surg Clin North Am. 1994;74:261–91.PubMedGoogle Scholar
  26. 26.
    Dunne JR, Malone DL, Tracy JK, et al. Abdominal wall hernias: risk factors for infection and resource utilization. J Surg Res. 2003;111:78–84.PubMedCrossRefGoogle Scholar
  27. 27.
    Casellas F, Sardi J, de Torres I, et al. Hydrogen breath test with D-xylose for celiac disease screening is as useful in the elderly as in other age groups. Dig Dis Sci. 2001;46:2201–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Gasbarrini G, Ciccocioppo R, De Vitis I, et al. Coeliac disease in the elderly. A multicentre Italian study. Gerontology. 2001;47:306–10.PubMedCrossRefGoogle Scholar
  29. 29.
    Robertson DJ, Grimm IS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 2001;30:409–26.PubMedCrossRefGoogle Scholar
  30. 30.
    Wagtmans MJ, Verspaget HW, Lamers CB, et al. Crohn’s disease in the elderly: a comparison with young adults. J Clin Gastroenterol. 1998;27:129–33.PubMedCrossRefGoogle Scholar
  31. 31.
    Holt PR. Diarrhea and malabsorption in the elderly. Gastroenterol Clin North Am. 2001;30:427–44.PubMedCrossRefGoogle Scholar
  32. 32.
    Taslim H, Taslim H. Clostridium difficile infection in the elderly. Acta Med Indones. 2009;41:148–51.PubMedGoogle Scholar
  33. 33.
    Kelly CP, LaMont JT, Kelly C, et al. Clostridium difficile–more difficult than ever. N Eng J Med. 2008;359:1932–40.CrossRefGoogle Scholar
  34. 34.
    Sailhamer EA, Carson K, Chang Y, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg 2009;144:433–9; discussion 439–40.Google Scholar
  35. 35.
    Cober ED, Malani PN, Cober ED, et al. Clostridium difficile infection in the “oldest” old: clinical outcomes in patients aged 80 and older. J Am Geriatr Soc. 2009;57:659–62.PubMedCrossRefGoogle Scholar
  36. 36.
    Jaber MR, Olafsson S, Fung WL, et al. Clinical review of the management of fulminant Clostridium difficile infection. Am J Gastroenterol. 2008;103:3195–203.PubMedCrossRefGoogle Scholar
  37. 37.
    Zilberberg MD, Shorr AF, Micek ST, et al. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med. 2009;37:2583–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Comparato G, Pilotto A, Franz A, et al. Diverticular disease in the elderly. Dig Dis. 2007;25:151–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Kang JY, Melville D, Maxwell JD, et al. Epidemiology and management of diverticular disease of the colon. Drugs Aging. 2004;21:211–28.PubMedCrossRefGoogle Scholar
  40. 40.
    Farrell RJ, Farrell JJ, Morrin MM. Diverticular disease in the elderly. Gastroenterol Clin North Am. 2001;30:475–96.PubMedCrossRefGoogle Scholar
  41. 41.
    Pfeifer J. Diverticulitis. Acta Chir Iugosl. 2008;55:97–102.PubMedCrossRefGoogle Scholar
  42. 42.
    Arai T, Kasahara I, Sawabe M, et al. Role of methylation of the hMLH1 gene promoter in the development of gastric and colorectal carcinoma in the elderly. Geriatr Gerontol Int. 2010;10 Suppl 1:S207–12.PubMedCrossRefGoogle Scholar
  43. 43.
    McMahon BJ. Natural history of chronic hepatitis B. Clin Liver Dis. 2010;14:381–96.PubMedCrossRefGoogle Scholar
  44. 44.
    Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Eng J Med. 1993;328:1433–7.CrossRefGoogle Scholar
  45. 45.
    Saif MW, Makrilia N, Zalonis A, et al. Gastric cancer in the elderly: an overview. Eur J Surg Oncol. 2010;36:709–17.PubMedCrossRefGoogle Scholar
  46. 46.
    SEER 17 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana and New Jersey). Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups—Census P25-1130). The modeled rates are the point estimates for the regression lines calculated by the Jointpoint Regression Program (Version 3.4.3, April 2010, National Cancer Institute)Google Scholar
  47. 47.
    Altekruse SF, Kosary CL, Krapcho M, et al. editors. SEER cancer statistics review, 1975–2007 (based on November 2009 SEER data submission, posted to the SEER web site). Bethesda, MD: National Cancer Institute; 2010.
  48. 48.
    Balbuena L, Casson AG, Balbuena L, et al. Physical activity, obesity and risk for esophageal adenocarcinoma. Future Oncol. 2009;5:1051–63.PubMedCrossRefGoogle Scholar
  49. 49.
    Vial M, Grande L, Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1–17.PubMedCrossRefGoogle Scholar
  50. 50.
    Bechade D, Blondon H, Sekkach Y, et al. Review of the association between obesity and gastroesophageal reflux and its complications. Gastroenterol Clin Biol. 2009;33:155–66.PubMedCrossRefGoogle Scholar
  51. 51.
    Jatoi A, Foster NR, Egner JR, et al. Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials. Int J Oncol. 2010;36:601–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004;64:2634–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.PubMedCrossRefGoogle Scholar
  54. 54.
    Simons JP, Ng SC, McDade TP, et al. Progress for resectable cancer?: a population-based assessment of US practices. Cancer. 2010;116:1681–90.PubMedCrossRefGoogle Scholar
  55. 55.
    Arber N, Eagle CJ, Spicak J, et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Eng J Med. 2006;355:885–95.CrossRefGoogle Scholar
  56. 56.
    Solomon SD, Pfeffer MA, McMurray JJ, et al. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation. 2006;114:1028–35.PubMedCrossRefGoogle Scholar
  57. 57.
    Rex DK, Lehman GA, Ulbright TM, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol. 1993;88:825–31.PubMedGoogle Scholar
  58. 58.
    Khullar SK, DiSario JA. Colon cancer screening. Sigmoidoscopy or colonoscopy. Gastrointest Endosc Clin N Am. 1997;7:365–86.PubMedGoogle Scholar
  59. 59.
    Lewis CL, Griffith J, Pignone MP, et al. Physicians’ decisions about continuing or stopping colon cancer screening in the elderly: a qualitative study. J Gen Intern Med. 2009;24:816–21.PubMedCrossRefGoogle Scholar
  60. 60.
    Fata F, Mirza A, Craig G, et al. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center. Cancer. 2002;94:1931–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Gastroenterology, Hepatology and NutritionUniversity of Pittsburgh School of MedicinePittsburghUSA
  2. 2.Department of Internal MedicineUniversity of Pittsburgh Medical CenterPittsburghUSA
  3. 3.Division of Gastroenterology and Hepatology, Department of Internal MedicineUniversity of Pittsburgh Medical CenterPittsburghUSA

Personalised recommendations